Paciaroni, K. et al. 2025. THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib.: Dual Myeloid Disorder Treated with Two Drug Association. Mediterranean Journal of Hematology and Infectious Diseases. 17, 1 (Feb. 2025), e2025023. DOI:https://doi.org/10.4084/MJHID.2025.023.